CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA-2 explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA-2 trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to find better treatment for aggressive blood disorders
Disease control OngoingThis study aims to find the most effective drug combination for treating higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), which are serious blood and bone marrow disorders. Researchers are comparing a standard chemotherapy drug (azacitidine)…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
New Two-Drug attack on tough blood cancers
Disease control OngoingThis study is testing a two-drug combination for adults with certain advanced blood cancers, including chronic myelomonocytic leukemia (CMML). The goal is to find the safest and most effective dose of a targeted drug (tagraxofusp) that delivers a toxin directly to cancer cells, c…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC